• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COBAS B 221 <6> SYSTEM; BLOOD GAS ANALYZER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COBAS B 221 <6> SYSTEM; BLOOD GAS ANALYZER Back to Search Results
Catalog Number 03337154001
Device Problem Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/17/2022
Event Type  malfunction  
Manufacturer Narrative
The field service engineer found a contaminated cuvette.The investigation is ongoing.
 
Event Description
The initial reporter received questionable bilirubin results for one patient tested on a cobas b 221 6 roche omni s6 system.The patient's cobas 221 bilirubin result was 7.5 mg/dl.The bilirubin result did not match the patient's clinical status and the medical personnel requested a laboratory test.Within 25 minutes, the patient's total bilirubin result on a "humastar 600- humastar 200" laboratory analyzer was 10.73 mg/dl.The customer determined the laboratory result to be correct and the diagnosis and treatment were based on the laboratory result.The bilirubin reagent lot number and expiration date were requested but not provided.
 
Manufacturer Narrative
The results were obtained with separate patient samples.Another sample for the same patient was measured on 18-jun-2022 and the bilirubin result was 7.1 mg/dl for an arterial blood sample.The hematocrit (hct) was 57.2 % and the thb was 19.28 g/dl.The hct and thb values were in the normal physiological reference ranges for neonates.The (mchc = hemoglobin (g/dl) : hematocrit) result was 33.71 g/dl which indicated an adequate thb-hct proportion.The b 221 bilirubin value was plausible regarding the hct value and the sample measurement result from the next day.For the plasma sample, only the bilirubin results were visible and no plausibility check could be performed.It was unknown why the customer thought that the even higher bilirubin value was correct.It was not clear if the cuvette was contaminated before or after the issue.The customer's qc values for bilirubin and all coox parameters were within range.The qc combitrol plus b material for level 2 and level 3 had expired on 31-may-2022.Expired material should not have been used for validating the parameter performance of the b 221.On 17-jun-2022 a "separator error" appeared frequently on the b 221.Based on the provided data no sample-related issue could be identified.For the b 221 sample, a syringe was used for venous blood sampling.The use of syringes greatly increases the risk of hemolysis and clot formation.The investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS B 221 <6> SYSTEM
Type of Device
BLOOD GAS ANALYZER
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key15086608
MDR Text Key304547502
Report Number1823260-2022-02159
Device Sequence Number1
Product Code CHL
UDI-Device Identifier04015630018345
UDI-Public04015630018345
Combination Product (y/n)N
Reporter Country CodeCO
PMA/PMN Number
K032311
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number03337154001
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/28/2022
Initial Date FDA Received07/22/2022
Supplement Dates Manufacturer Received08/19/2022
Supplement Dates FDA Received09/12/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age2 DA
Patient SexFemale
-
-